ID: ALA5208212

Max Phase: Preclinical

Molecular Formula: C24H25NO4

Molecular Weight: 391.47

Associated Items:

Representations

Canonical SMILES:  COC(=O)[C@H](Cc1ccc(O)c(O)c1)N(Cc1ccccc1)Cc1ccccc1

Standard InChI:  InChI=1S/C24H25NO4/c1-29-24(28)21(14-20-12-13-22(26)23(27)15-20)25(16-18-8-4-2-5-9-18)17-19-10-6-3-7-11-19/h2-13,15,21,26-27H,14,16-17H2,1H3/t21-/m0/s1

Standard InChI Key:  ZCVCVVNJRDXBEH-NRFANRHFSA-N

Associated Targets(Human)

Vanilloid receptor 8273 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

LNCaP 8286 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PNT2 51 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PC-3 62116 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Transient receptor potential cation channel subfamily M member 8 889 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 391.47Molecular Weight (Monoisotopic): 391.1784AlogP: 3.88#Rotatable Bonds: 8
Polar Surface Area: 70.00Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.29CX Basic pKa: 6.74CX LogP: 4.88CX LogD: 4.79
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.45Np Likeness Score: 0.11

References

1. Di Sarno V, Giovannelli P, Medina-Peris A, Ciaglia T, Di Donato M, Musella S, Lauro G, Vestuto V, Smaldone G, Di Matteo F, Bifulco G, Castoria G, Migliaccio A, Fernandez-Carvajal A, Campiglia P, Gomez-Monterrey I, Ostacolo C, Bertamino A..  (2022)  New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models.,  238  [PMID:35598411] [10.1016/j.ejmech.2022.114435]

Source